Cargando…

Development and performance of CUHAS-ROBUST application for pulmonary rifampicin-resistance tuberculosis screening in Indonesia

BACKGROUND AND OBJECTIVES: Diagnosis of Pulmonary Rifampicin Resistant Tuberculosis (RR-TB) with the Drug-Susceptibility Test (DST) is costly and time-consuming. Furthermore, GeneXpert for rapid diagnosis is not widely available in Indonesia. This study aims to develop and evaluate the CUHAS-ROBUST...

Descripción completa

Detalles Bibliográficos
Autores principales:	Herman, Bumi, Sirichokchatchawan, Wandee, Pongpanich, Sathirakorn, Nantasenamat, Chanin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993842/ https://www.ncbi.nlm.nih.gov/pubmed/33765092 http://dx.doi.org/10.1371/journal.pone.0249243

Ejemplares similares

Practice, confidence and continuity of breast self-examination among women in Thailand during COVID-19 pandemic: a cross-sectional study
por: Taneepanichskul, Surasak, et al.
Publicado: (2023)

Occupational Injuries and Illnesses and Associated Costs in Thailand
por: Thepaksorn, Phayong, et al.
Publicado: (2014)

Estimating Long-Term Care Costs among Thai Elderly: A Phichit Province Case Study
por: Khongboon, Pattaraporn, et al.
Publicado: (2018)

The impact of National Health Insurance upon accessibility of health services and financial protection from catastrophic health expenditure: a case study of Savannakhet province, the Lao People’s Democratic Republic
por: Bodhisane, Somdeth, et al.
Publicado: (2019)

The influence of the National Health Insurance scheme of the Lao People’s Democratic Republic on healthcare access and catastrophic health expenditures for patients with chronic renal disease, and the possibility of integrating organ transplantation into the health financing system
por: Bodhisane, Somdeth, et al.
Publicado: (2022)

Laos’ Social Health Insurance (SHI) program’s impact on older people’s accessibility and financial security against catastrophic health expense
por: Bodhisane, Somdeth, et al.
Publicado: (2023)

Airway microecology in rifampicin-resistant and rifampicin-sensitive pulmonary tuberculosis patients
por: Cai, Xingshan, et al.
Publicado: (2022)

Access to health care: the role of a community based health insurance in Kenya
por: Mwaura, Judy Wanja, et al.
Publicado: (2012)

Perspectives and experiences of Thai adults using wheelchairs regarding barriers of access to dental services: a mixed methods study
por: Sermsuti-anuwat, Nithimar, et al.
Publicado: (2018)

Risk Factors for Six Types of Disability among the Older People in Thailand in 2002, 2007, and 2011
por: Khongboon, Pattaraporn, et al.
Publicado: (2016)

Application of the Multistate Tuberculosis Pharmacometric Model in Patients With Rifampicin‐Treated Pulmonary Tuberculosis
por: Svensson, RJ, et al.
Publicado: (2016)

Prevalence of rifampicin resistance by automated Genexpert rifampicin assay in patients with pulmonary tuberculosis in Yenagoa, Nigeria
por: Ikuabe, Peter Ogie, et al.
Publicado: (2018)

Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis
por: te Brake, Lindsey H. M., et al.
Publicado: (2019)

Protective Effects of Cell-Free Supernatant and Live Lactic Acid Bacteria Isolated from Thai Pigs Against a Pandemic Strain of Porcine Epidemic Diarrhea Virus
por: Sirichokchatchawan, Wandee, et al.
Publicado: (2017)

Prevalence of rifampicin resistant tuberculosis among pulmonary tuberculosis patients In Enugu, Nigeria
por: Ulasi, Amara, et al.
Publicado: (2022)

Determinants of newborn care utilization in Pakistan: Findings from the Demographic and Health Surveys
por: Pongpanich, Sathirakorn, et al.
Publicado: (2020)

Concentrations of rifampicin in pre-dose samples in patients with pulmonary tuberculosis
por: Uchoa, Breno Kristoffer Beleza, et al.
Publicado: (2019)

Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis
por: Zhang, Zehua, et al.
Publicado: (2014)

Age, comorbidities, c-reactive protein and procalcitonin as predictors of severity in confirmed COVID-19 patients in the Philippines
por: Acedera, Marjonel L., et al.
Publicado: (2023)

Post-COVID depression and its multiple factors, does Favipiravir have a protective effect? A longitudinal study of indonesia COVID-19 patients
por: Herman, Bumi, et al.
Publicado: (2022)

Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence
por: Rockwood, Neesha, et al.
Publicado: (2017)

Antenatal depressive symptoms are strongly predicted by the severity of pre-menstrual syndrome: results of partial least squares analysis
por: Abe, Yoshiko, et al.
Publicado: (2023)

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
por: Steingart, Karen R, et al.
Publicado: (2014)

Xpert® Mtb/Rif assay for pulmonary tuberculosis and rifampicin resistance in adults
por: Steingart, Karen R, et al.
Publicado: (2013)

The Population Pharmacokinetics of Meropenem in Adult Patients With Rifampicin-Sensitive Pulmonary Tuberculosis
por: Abulfathi, Ahmed A., et al.
Publicado: (2021)

Oral rifampicin interferes with urine dipstick tests for patients with pulmonary tuberculosis
por: Wang, Fei, et al.
Publicado: (2023)

Drug interaction potential of high-dose rifampicin in patients with pulmonary tuberculosis
por: Stemkens, Ralf, et al.
Publicado: (2023)

Burden of Pulmonary Rifampicin-Resistant Tuberculosis in Kajiado, Kenya: An Observational Study
por: Cattaneo, Paolo, et al.
Publicado: (2023)

Expediting support for the pregnant mothers to obtain antenatal care at public health facilities in rural areas of Balochistan province, Pakistan
por: Ghaffar, Abdul, et al.
Publicado: (2015)

Determinants of the food insecurity at household level in Pakistan: A multilevel model approach
por: Mahmood, Tahir, et al.
Publicado: (2023)

Toward insights on determining factors for high activity in antimicrobial peptides via machine learning
por: Li, Hao, et al.
Publicado: (2019)

Evaluation of Xpert MTB-RIF guided diagnosis and treatment of rifampicin-resistant tuberculosis in Indonesia: A retrospective cohort study
por: Soeroto, Arto Yuwono, et al.
Publicado: (2019)

Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms
por: Shapiro, Adrienne E, et al.
Publicado: (2021)

Pyrazinamide resistance in rifampicin discordant tuberculosis
por: Mvelase, Nomonde Ritta, et al.
Publicado: (2022)

Rifampicin Pulmospheres for Pulmonary Delivery
por: Morde, M. A., et al.
Publicado: (2009)

Prevalence of Rifampicin-Resistant Tuberculosis among Patients Previously Treated for Pulmonary Tuberculosis in North-Western, Nigeria
por: Fadeyi, Abayomi, et al.
Publicado: (2017)

Rifampicin resistant Mycobacterium tuberculosis and associated factors among presumptive pulmonary tuberculosis patients in Mogadishu, Somalia
por: Ali, Mohamed Muhumed, et al.
Publicado: (2023)

Systematic Review of the Performance of Rapid Rifampicin Resistance Testing for Drug-Resistant Tuberculosis
por: Arentz, Matthew, et al.
Publicado: (2013)

Diagnostic performance of DNA microarray for detecting rifampicin and isoniazid resistance in Mycobacterium tuberculosis
por: Sun, Bingqi, et al.
Publicado: (2021)

Effectiveness of health education intervention on diabetes mellitus among the teachers working in public sector schools of Pakistan
por: Kumar, Ramesh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pvohdnkfkaub4tjfopipni2hlm